McKesson Corp (NYSE:MCK)

Spooky27 (96.06) Submitted: 3/19/2007 5:45:29 PM : Start Price: $54.04 MCK Score: +62.58

I think this is a good company with a good industies and with researchers developing new drugs that help our body i say get in before major break threws happen!

maverickpl (92.78) Submitted: 2/22/2007 11:48:14 AM : Start Price: $54.77 MCK Score: +63.75

I own it, so I'm blinded by greed.

grochen (52.40) Submitted: 2/22/2007 3:23:29 AM : Start Price: $54.92 MCK Score: +63.67

following jim cramer

TradeMarket (95.49) Submitted: 1/3/2007 7:15:20 PM : Start Price: $47.14 MCK Score: +86.66

Great L.R. growth potential. Medical industry in years behind in adoption of I.T., and this firm is firmly set to capitalize on the serious growth in the coming years.

dilettantedude (96.14) Submitted: 11/9/2006 8:48:52 AM : Start Price: $48.20 MCK Score: +81.09

Three things are driving McKesson: rapid development of new drugs; demographics; and Medicare Part D. ROIC is high, and the company is selling for only half its estimated fair value based on discounted free cash flow. Their transition to a fee-for-service business model, which hurt the distribitors last year, appears to have been very successful in boosting margins and ROIC, so the reason for the drop in price seems to be behind them.

ptevans (< 20) Submitted: 9/4/2006 2:44:27 PM : Start Price: $49.56 MCK Score: +69.83

has marketshare via hospitals and clinics.